Rivastigmine Sandoz

Medicinal product

(Invented) name

Rivastigmine Sandoz

Active substance (s)

Rivastigminas

Strength

1,5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N06DA03, Rivastigmine

Marketing authorisation holder

Sandoz GmbH, Austrija

Date of authorisation

2009-12-11

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Capsule, hard	1 vnt.
Rivastigminas	1,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
38983	52666	1052666	lizdinė plokštelė	N28		Receptinis	EU/1/09/599/001	Netiekiama	-	-	No	-	-
38984	52667	1052667	lizdinė plokštelė	N56		Receptinis	EU/1/09/599/002	Netiekiama	-	-	No	-	-
38985	52668	1052668	lizdinė plokštelė	N112		Receptinis	EU/1/09/599/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2009-12-11	Registruotas